Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.BMS, Compugen to evaluate Opdivo-COM701 combo in advanced solid tumors
Image: Bristol-Myers Squibb enters into clinical trial collaboration with Compugen to evaluate COM701, Opdivo combo. Photo: courtesy of Sue Adair/Commons.wikimedia.org.
Image: Bristol-Myers Squibb enters into clinical trial collaboration with Compugen to evaluate COM701, Opdivo combo. Photo: courtesy of Sue Adair/Commons.wikimedia.org.